Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi Directional Device in Subjects With Bilateral Nasal Polyposis Followed by an 8-Week Open-Label Extension Phase to Assess Safety

ClinicalTrials.gov ID: NCT01622569

Public ClinicalTrials.gov record NCT01622569. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 16-Week Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi Directional Device in Subjects With Bilateral Nasal Polyposis Followed by an 8-Week Open-Label Extension Phase to Assess Safety

Study identification

NCT ID
NCT01622569
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Optinose US Inc.
Industry
Enrollment
323 participants

Conditions and interventions

Interventions

  • Fluticasone Propionate Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 18, 2013
Primary completion
Aug 5, 2015
Completion
Sep 30, 2015
Last update posted
Dec 25, 2018

2013 – 2015

United States locations

U.S. sites
30
U.S. states
16
U.S. cities
28
Facility City State ZIP Site status
SC Clinical Research, Inc. Tucson Arizona 85704
Kern Allergy and Medical Research, Inc. Bakersfield California 93301
Central California Clinical Research Fresno California 93720
Allergy & Asthma Specialists Medical Group Huntington Beach California 92647
California Allergy & Asthma Medical Group, Inc. Los Angeles California 90025
Choc PSF, AMC, Division of AA & I Orange California 92868
California Allergy and Asthma Palmdale Palmdale California 93551
Peninsula Research Associates, Inc. Rolling Hills Estates California 90274
California Medical Clinic for Headache Santa Monica California 90404
Asthma & Allergy Associates, P.C. Colorado Springs Colorado 80907
Colorado ENT & Allergy Colorado Springs Colorado 80909
Colorado Allergy and Asthma Centers, P.C. Denver Colorado 80230
University of South Florida Asthma, Allergy & Immunology Tampa Florida 33613
NU Feinberg School of Medicine Depart. of Otolaryngology-Head & Neck Surgery Chicago Illinois 60611
Chicago ENT Chicago Illinois 60657
Northeast Medical Research Associates, Inc North Dartmouth Massachusetts 02747
The Center for Pharmaceutical Research, P.C. Kansas City Missouri 64114
Clinical Research Group of Montana, PLLC Bozeman Montana 59718
Coastal Ear, Nose and Throat, LLC Neptune City New Jersey 07753
Montefiore Medical Center The Bronx New York 10467
Cleveland Clinic Cleveland Ohio 44195
Optimed Research Columbus Ohio 43235
Allergy, Asthma & Clinical Research Center Oklahoma City Oklahoma 73120
Vital Prospects Clinical Research Institute Tulsa Oklahoma 74136
National Allergy, Asthma & Urticaria Centers of Charleston, P.A. North Charleston South Carolina 29420
AARA Research Center Dallas Texas 75231
Ear Nose and Throat Associates of Texas Frisco Texas 43235
ENTTEX Plano Texas 75093
EVMS Depart. Of Otolaryngology Norfolk Virginia 23507
Allergy, Asthma & Sinus Center, S.C. Greenfield Wisconsin 53228

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01622569, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 25, 2018 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01622569 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →